Molecular Diagnostics Market to Expand at a CAGR of 11.6% by 2025
Molecular diagnostics is an integral part of the in vitro diagnostics industry and has gained an accelerated momentum in recent years. The introduction of tests for Chlamydia trachomatis and Neisseria gonorrhea (CT/NG) and HIV have augmented the demand for PCR technology have completely transformed the earnings of this market over the past two decades.
View full press release